Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. The pancreas is an organ that makes enzymes for ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...

The most common pathology affecting the pancreas is excess intra-pancreatic fat deposition (IPFD), often called fatty pancreas disease (FPD) — a disorder experienced by roughly one fifth of the ...

Researchers at Detroit-based Karmanos Cancer Institute are harnessing robotic technology to accelerate the search for more effective pancreatic cancer treatments for pancreatic cancer, which has one ...

Pancreatic cancer is often advanced by the time it’s diagnosed. It’s very common for it to spread to other parts of the body. Many people have advanced pancreatic cancer at the time of diagnosis.

Tokyo, Japan – Researchers from Tokyo Metropolitan University have studied pancreatic islet cell loss in people with no previous pancreatic problems. They identified key trends in the types of cells ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...